“CSL has an outstanding track record over the long term,” said David Grace of the Australian Foundation Investment Company, which owns about A$629 million of the company’s shares and has been invested ...
BioSyent Inc. (CVE:RX – Get Free Report) insider FAX Capital Corp. sold 230,800 shares of BioSyent stock in a transaction on Friday, November 22nd. The stock was sold at an average price of C$11.12, ...